Cargando…

Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy

Detalles Bibliográficos
Autores principales: De Greef, Julien, Devresse, Arnaud, Saad Albichr, Imane, Scohy, Anais, Kanaan, Nada, Georgery, Hélène, Belkhir, Leila, Kabamba, Benoit, Yombi, Jean Cyr, Goffin, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405446/
https://www.ncbi.nlm.nih.gov/pubmed/34478748
http://dx.doi.org/10.1016/j.kint.2021.08.018
_version_ 1783746337722859520
author De Greef, Julien
Devresse, Arnaud
Saad Albichr, Imane
Scohy, Anais
Kanaan, Nada
Georgery, Hélène
Belkhir, Leila
Kabamba, Benoit
Yombi, Jean Cyr
Goffin, Eric
author_facet De Greef, Julien
Devresse, Arnaud
Saad Albichr, Imane
Scohy, Anais
Kanaan, Nada
Georgery, Hélène
Belkhir, Leila
Kabamba, Benoit
Yombi, Jean Cyr
Goffin, Eric
author_sort De Greef, Julien
collection PubMed
description
format Online
Article
Text
id pubmed-8405446
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84054462021-08-31 Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy De Greef, Julien Devresse, Arnaud Saad Albichr, Imane Scohy, Anais Kanaan, Nada Georgery, Hélène Belkhir, Leila Kabamba, Benoit Yombi, Jean Cyr Goffin, Eric Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-11 2021-08-31 /pmc/articles/PMC8405446/ /pubmed/34478748 http://dx.doi.org/10.1016/j.kint.2021.08.018 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
De Greef, Julien
Devresse, Arnaud
Saad Albichr, Imane
Scohy, Anais
Kanaan, Nada
Georgery, Hélène
Belkhir, Leila
Kabamba, Benoit
Yombi, Jean Cyr
Goffin, Eric
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
title Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
title_full Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
title_fullStr Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
title_full_unstemmed Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
title_short Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
title_sort better late than never: eventual seroconversion against sars-cov-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405446/
https://www.ncbi.nlm.nih.gov/pubmed/34478748
http://dx.doi.org/10.1016/j.kint.2021.08.018
work_keys_str_mv AT degreefjulien betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT devressearnaud betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT saadalbichrimane betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT scohyanais betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT kanaannada betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT georgeryhelene betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT belkhirleila betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT kabambabenoit betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT yombijeancyr betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy
AT goffineric betterlatethannevereventualseroconversionagainstsarscov2inakidneytransplantrecipientafterrepeatedimmunechallengeandmonoclonalantibodytherapy